MIRAI demonstrated stronger discriminatory accuracy than clinical models for five-year overall and invasive bc risk prediction but overestimated risk for both bc endpoints. AI-based risk models should consider discriminatory accuracy and calibration for invasive cancer before implementation.
Kaul et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: